Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 5/20 | 0.76 |
| ▸ | MMP2 | P08253 | 10/20 | 0.71 |
| ▸ | MMP9 | P14780 | 8/20 | 0.71 |
| ▸ | MMP8 | P22894 | 8/20 | 0.71 |
| ▸ | MMP1 | P03956 | 7/20 | 0.71 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.66 |
| ▸ | ADAM12 | O43184 | 1/20 | 0.66 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.66 |
| ▸ | MMP3 | P08254 | 1/20 | 0.66 |
| ▸ | MMP7 | P09237 | 1/20 | 0.66 |
| ▸ | MMP12 | P39900 | 1/20 | 0.66 |
| ▸ | MMP13 | P45452 | 1/20 | 0.66 |
| ▸ | MMP14 | P50281 | 1/20 | 0.66 |
| ▸ | MMP15 | P51511 | 1/20 | 0.66 |
| ▸ | MMP16 | P51512 | 1/20 | 0.66 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.66 |
| ▸ | ADAM9 | Q13443 | 1/20 | 0.66 |
| ▸ | MMP26 | Q9NRE1 | 1/20 | 0.66 |
| ▸ | MMP17 | Q9ULZ9 | 1/20 | 0.66 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7371076 | 1.00 | ECE1 (0.76) | ECE1MMP2MMP9MMP8MMP1 | |
| SCHEMBL6578096 | 0.91 | MMP2 (0.82) | MMP2MMP9MMP8MMP1ADAM10 | |
| SCHEMBL851449 | 0.91 | MMP2 (0.82) | MMP2MMP9MMP8MMP1ADAM10 | |
| SCHEMBL6575025 | 0.91 | MMP2 (0.85) | ECE1MMP2MMP9MMP8MMP1 | |
| SCHEMBL4795667 | 0.91 | MMP2 (0.85) | ECE1MMP2MMP9MMP8MMP1 | |
| SCHEMBL6577835 | 0.89 | MMP1 (0.68) | MMP2MMP9MMP8MMP1ADAM10 | |
| SCHEMBL6575260 | 0.89 | MMP2 (0.66) | ECE1MMP2MMP9MMP8MMP1 | |
| SCHEMBL4845965 | 0.88 | MMP2 (0.84) | ECE1MMP2MMP9MMP8MMP1 | |
| SCHEMBL9068557 | 0.87 | ECE1 (1.00) | ECE1ACE | |
| SCHEMBL6431194 | 0.86 | ECE1 (0.79) | ECE1MMP2MMP9MMP8MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0558648-B1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY RICHARD E (US) | 2004-04-28 | — | — | EP | disclosed |
| US-6187907-B1 | CONJUGATE OF THREE CROSSLINKED POLYPEPTIDE CHAINS CONTAINING TRIPEPTIDE OR HEXAPEPTIDE REPEAT SEQUENCES ALIGNED TO FORM TRIPLE HELIX COIL AND LIGAND COVALENTLY ATTATCHED TO TEMPLATE; MODELING; DRUG SCREENING | CHEN JAMES (US) | 2001-02-13 | — | — | US | disclosed |
| EP-0663823-B1 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED INC (US) | 2000-11-22 | — | — | EP | disclosed |
| WO-2000012538-A1 | TRIPLE HELIX COIL TEMPLATE HAVING A BIOLOGICALLY ACTIVE LIGAND | CHEN JAMES (US) | 2000-03-09 | — | — | WO | disclosed |
| US-5892112-A | ACYLATION OF AMINO ACIDS WITH ANHYDRIDES OR CARBOXY GROUPS, AMIDATION WITH AMINE AND CONVERSION OF ACID OR ESTER TO HYDROXAMIC ACID AND HYDROLYSIS | GLYCOMED INCORPORATED (US) | 1999-04-06 | — | — | US | disclosed |
| US-5773438-A | SKIN DISORDERS, RESTENOSIS, RHEUMATIC ARTHRITIS, WOUND HEALING AGENTS, ANGIOGENESIS, SHOCK | GLYCOMED INCORPORATED (US) | 1998-06-30 | — | — | US | disclosed |
| EP-0558681-B1 | TREATMENT FOR TISSUE ULCERATION | UNIV FLORIDA (US) | 1998-04-08 | — | — | EP | disclosed |
| EP-0558635-B1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED INC (US) | 1997-09-10 | — | — | EP | disclosed |
| EP-0663823-A4 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS. | GLYCOMED INC (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0692931-A4 | SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF | GLYCOMED INC (US) | 1996-03-20 | — | — | EP | disclosed |
| EP-0558648-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY, Richard, E. (US) | 1993-09-08 | — | — | EP | disclosed |
| EP-0558635-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS. | GLYCOMED INC (US) | 1993-09-08 | — | — | EP | disclosed |
| US-5239078-A | Collagenase enzyme inhibitors | GLYCOMED INCORPORATED (US) | 1993-08-24 | — | — | US | disclosed |
| WO-1993013741-A2 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED, INC. (US) | 1993-07-22 | — | — | WO | disclosed |
| US-5189178-A | Preventing protein destruction | GALARDY RICHARD E (US) | 1993-02-23 | — | — | US | disclosed |
| US-5183900-A | Matrix metalloprotease inhibitors | GALARDY RICHARD E (US) | 1993-02-02 | — | — | US | disclosed |
| WO-1992009563-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED, INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009556-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY RICHARD E (US) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009282-A1 | TREATMENT FOR TISSUE ULCERATION | THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| US-5114953-A | Peptides | UNIVERSITY OF FLORIDA (US) | 1992-05-19 | — | — | US | disclosed |